The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[4-[(5-ethyl-11-methyl-6-oxo-pyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]-3-methoxy-phenyl]methanesulfonamide ID: ALA4644273
PubChem CID: 134457677
Max Phase: Preclinical
Molecular Formula: C22H24N6O4S
Molecular Weight: 468.54
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCN1C(=O)c2ccccc2N(C)c2nc(Nc3ccc(NS(C)(=O)=O)cc3OC)ncc21
Standard InChI: InChI=1S/C22H24N6O4S/c1-5-28-18-13-23-22(24-16-11-10-14(12-19(16)32-3)26-33(4,30)31)25-20(18)27(2)17-9-7-6-8-15(17)21(28)29/h6-13,26H,5H2,1-4H3,(H,23,24,25)
Standard InChI Key: JVVFSGBLMWRDED-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 36 0 0 0 0 0 0 0 0999 V2000
24.4383 -17.4073 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.0180 -17.9932 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
25.2325 -17.1923 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.8167 -18.2070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4373 -18.5738 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.6386 -18.3640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0595 -18.9464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2597 -18.7351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0444 -17.9356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6295 -17.3509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4157 -16.5522 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.0005 -15.9715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4245 -17.5649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2457 -17.7217 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.0317 -16.9230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2270 -16.7933 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.9377 -16.0206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4630 -15.3895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2637 -15.5264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5514 -16.2946 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.2833 -14.5862 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.8639 -14.0013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6542 -13.2068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5406 -14.2212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5406 -13.3948 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.7974 -14.5662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1946 -13.9959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4063 -14.2344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2140 -15.0366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8134 -15.6036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6055 -15.3693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1117 -16.0206 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.7005 -16.7348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
2 3 2 0
2 4 1 0
5 2 1 0
6 5 1 0
7 6 1 0
8 7 2 0
9 8 1 0
10 9 2 0
10 11 1 0
11 12 1 0
13 10 1 0
6 13 2 0
14 9 1 0
15 14 1 0
16 15 2 0
17 16 1 0
18 17 2 0
18 19 1 0
20 19 2 0
15 20 1 0
21 18 1 0
21 22 1 0
22 23 1 0
24 21 1 0
24 25 2 0
26 24 1 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
31 30 1 0
26 31 2 0
31 32 1 0
32 17 1 0
32 33 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 468.54Molecular Weight (Monoisotopic): 468.1580AlogP: 3.35#Rotatable Bonds: 6Polar Surface Area: 116.76Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.57CX Basic pKa: 3.31CX LogP: 1.98CX LogD: 1.98Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.57Np Likeness Score: -1.47
References 1. Ferguson FM, Liu Y, Harshbarger W, Huang L, Wang J, Deng X, Capuzzi SJ, Muratov EN, Tropsha A, Muthuswamy S, Westover KD, Gray NS.. (2020) Synthesis and Structure-Activity Relationships of DCLK1 Kinase Inhibitors Based on a 5,11-Dihydro-6H -benzo[e ]pyrimido[5,4-b ][1,4]diazepin-6-one Scaffold., 63 (14): [PMID:32530623 ] [10.1021/acs.jmedchem.0c00596 ]